Savant Capital LLC Increases Stock Holdings in Centene Corporation $CNC

Savant Capital LLC grew its holdings in Centene Corporation (NYSE:CNC) by 71.7% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 143,321 shares of the company’s stock after buying an additional 59,848 shares during the period. Savant Capital LLC’s holdings in Centene were worth $5,114,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CNC. Vanguard Group Inc. grew its stake in shares of Centene by 1.5% during the 2nd quarter. Vanguard Group Inc. now owns 58,396,605 shares of the company’s stock worth $3,169,768,000 after purchasing an additional 869,706 shares during the period. Norges Bank acquired a new position in Centene during the second quarter worth about $1,435,997,000. State Street Corp lifted its position in shares of Centene by 2.3% during the 2nd quarter. State Street Corp now owns 23,186,927 shares of the company’s stock valued at $1,258,586,000 after acquiring an additional 514,600 shares during the period. Geode Capital Management LLC grew its stake in Centene by 2.2% in the 2nd quarter. Geode Capital Management LLC now owns 13,208,639 shares of the company’s stock valued at $718,547,000 after acquiring an additional 279,637 shares during the last quarter. Finally, Invesco Ltd. raised its position in Centene by 5.7% during the second quarter. Invesco Ltd. now owns 11,725,910 shares of the company’s stock worth $636,482,000 after acquiring an additional 633,946 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Down 2.6%

Shares of NYSE CNC opened at $39.88 on Friday. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $19.60 billion, a PE ratio of -3.69, a P/E/G ratio of 0.95 and a beta of 0.48. The firm has a fifty day moving average of $42.04 and a 200-day moving average of $35.81. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.03.

Centene (NYSE:CNC) last posted its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.25) by $0.06. The firm had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a positive return on equity of 7.82% and a negative net margin of 2.85%.Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, analysts anticipate that Centene Corporation will post 6.86 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently commented on CNC. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research note on Wednesday, January 21st. Jefferies Financial Group upped their price objective on shares of Centene from $25.00 to $32.00 in a research note on Monday, November 3rd. Wells Fargo & Company set a $43.00 target price on shares of Centene and gave the stock an “equal weight” rating in a research note on Wednesday, January 7th. Oppenheimer reissued an “outperform” rating and set a $45.00 price target on shares of Centene in a research note on Thursday, October 30th. Finally, Robert W. Baird upped their target price on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Three investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, Centene currently has an average rating of “Hold” and an average price target of $40.81.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.